PillHydrocortisone Sodium Succinate
Brands: Solu-Cortef · Hydrocortisone Sodium Succinate
4 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Pharmacia & Upjohn Company LLC | unknown | 6 | SUPPLYING |
| ProPharma Distribution | unknown | 1 | SUPPLYING |
| Cardinal Health 107, LLC | unknown | 1 | SUPPLYING |
| Apotex Corp. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 24, 2026RESOLVEDShortage resolved: Hydrocortisone Sodium Succinate Injection (Hospira, Inc., a Pfizer Company)
Hydrocortisone Sodium Succinate Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Pediatric, Pulmonary/Allergy, Renal, Rheumatology.
- Mar 24, 2023SHORTAGEDrug shortage: Hydrocortisone Sodium Succinate Injection (Hospira, Inc., a Pfizer Company)
Hydrocortisone Sodium Succinate Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Pediatric, Pulmonary/Allergy, Renal, Rheumatology.